Phosphoglycan beta 1,3 galactosyltransferase (required for proper protective coat formation). Probably part of a much larger group. Expanded in Leishmaniids. Localization: Golgi (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 60 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 52 |
NetGPI | no | yes: 0, no: 52 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 53 |
GO:0110165 | cellular anatomical entity | 1 | 53 |
GO:0000139 | Golgi membrane | 5 | 13 |
GO:0031090 | organelle membrane | 3 | 13 |
GO:0098588 | bounding membrane of organelle | 4 | 13 |
Related structures:
AlphaFold database: E9ALD6
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 53 |
GO:0006807 | nitrogen compound metabolic process | 2 | 53 |
GO:0008152 | metabolic process | 1 | 53 |
GO:0019538 | protein metabolic process | 3 | 53 |
GO:0036211 | protein modification process | 4 | 53 |
GO:0043170 | macromolecule metabolic process | 3 | 53 |
GO:0043412 | macromolecule modification | 4 | 53 |
GO:0043413 | macromolecule glycosylation | 3 | 53 |
GO:0044238 | primary metabolic process | 2 | 53 |
GO:0070085 | glycosylation | 2 | 53 |
GO:0071704 | organic substance metabolic process | 2 | 53 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 53 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 53 |
GO:0016740 | transferase activity | 2 | 53 |
GO:0016757 | glycosyltransferase activity | 3 | 53 |
GO:0016758 | hexosyltransferase activity | 4 | 53 |
GO:0008194 | UDP-glycosyltransferase activity | 4 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.611 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.611 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.602 |
CLV_NRD_NRD_1 | 310 | 312 | PF00675 | 0.515 |
CLV_NRD_NRD_1 | 327 | 329 | PF00675 | 0.681 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.419 |
CLV_NRD_NRD_1 | 362 | 364 | PF00675 | 0.593 |
CLV_NRD_NRD_1 | 417 | 419 | PF00675 | 0.659 |
CLV_NRD_NRD_1 | 486 | 488 | PF00675 | 0.546 |
CLV_NRD_NRD_1 | 538 | 540 | PF00675 | 0.563 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.454 |
CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.611 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.634 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.592 |
CLV_PCSK_KEX2_1 | 310 | 312 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 327 | 329 | PF00082 | 0.679 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 362 | 364 | PF00082 | 0.593 |
CLV_PCSK_KEX2_1 | 538 | 540 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 595 | 597 | PF00082 | 0.611 |
CLV_PCSK_KEX2_1 | 601 | 603 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 609 | 611 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 657 | 659 | PF00082 | 0.543 |
CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.578 |
CLV_PCSK_PC1ET2_1 | 595 | 597 | PF00082 | 0.539 |
CLV_PCSK_PC1ET2_1 | 601 | 603 | PF00082 | 0.533 |
CLV_PCSK_PC1ET2_1 | 609 | 611 | PF00082 | 0.517 |
CLV_PCSK_PC1ET2_1 | 657 | 659 | PF00082 | 0.543 |
CLV_PCSK_PC7_1 | 4 | 10 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.600 |
CLV_PCSK_SKI1_1 | 328 | 332 | PF00082 | 0.597 |
CLV_PCSK_SKI1_1 | 490 | 494 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 525 | 529 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 557 | 561 | PF00082 | 0.522 |
DEG_SCF_FBW7_1 | 379 | 386 | PF00400 | 0.485 |
DEG_SPOP_SBC_1 | 357 | 361 | PF00917 | 0.337 |
DOC_CKS1_1 | 380 | 385 | PF01111 | 0.488 |
DOC_CYCLIN_yCln2_LP_2 | 176 | 182 | PF00134 | 0.344 |
DOC_CYCLIN_yCln2_LP_2 | 377 | 383 | PF00134 | 0.529 |
DOC_MAPK_gen_1 | 160 | 166 | PF00069 | 0.387 |
DOC_MAPK_gen_1 | 225 | 234 | PF00069 | 0.380 |
DOC_MAPK_gen_1 | 34 | 41 | PF00069 | 0.540 |
DOC_MAPK_gen_1 | 423 | 430 | PF00069 | 0.353 |
DOC_MAPK_JIP1_4 | 225 | 231 | PF00069 | 0.356 |
DOC_MAPK_MEF2A_6 | 34 | 43 | PF00069 | 0.566 |
DOC_MAPK_MEF2A_6 | 407 | 414 | PF00069 | 0.434 |
DOC_MAPK_MEF2A_6 | 463 | 472 | PF00069 | 0.298 |
DOC_MAPK_MEF2A_6 | 569 | 576 | PF00069 | 0.289 |
DOC_MAPK_NFAT4_5 | 407 | 415 | PF00069 | 0.333 |
DOC_MAPK_NFAT4_5 | 569 | 577 | PF00069 | 0.280 |
DOC_PP1_RVXF_1 | 427 | 433 | PF00149 | 0.377 |
DOC_PP1_RVXF_1 | 441 | 448 | PF00149 | 0.436 |
DOC_PP1_RVXF_1 | 515 | 521 | PF00149 | 0.301 |
DOC_PP1_RVXF_1 | 523 | 529 | PF00149 | 0.303 |
DOC_PP1_RVXF_1 | 621 | 627 | PF00149 | 0.311 |
DOC_PP2B_LxvP_1 | 377 | 380 | PF13499 | 0.532 |
DOC_PP2B_LxvP_1 | 470 | 473 | PF13499 | 0.308 |
DOC_PP4_FxxP_1 | 633 | 636 | PF00568 | 0.259 |
DOC_PP4_FxxP_1 | 80 | 83 | PF00568 | 0.436 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.397 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 168 | 172 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.355 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.434 |
DOC_USP7_MATH_1 | 298 | 302 | PF00917 | 0.407 |
DOC_USP7_MATH_1 | 312 | 316 | PF00917 | 0.385 |
DOC_USP7_MATH_1 | 562 | 566 | PF00917 | 0.289 |
DOC_USP7_UBL2_3 | 419 | 423 | PF12436 | 0.356 |
DOC_USP7_UBL2_3 | 647 | 651 | PF12436 | 0.319 |
DOC_WW_Pin1_4 | 318 | 323 | PF00397 | 0.331 |
DOC_WW_Pin1_4 | 345 | 350 | PF00397 | 0.490 |
DOC_WW_Pin1_4 | 379 | 384 | PF00397 | 0.457 |
DOC_WW_Pin1_4 | 617 | 622 | PF00397 | 0.342 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.472 |
LIG_14-3-3_CanoR_1 | 163 | 167 | PF00244 | 0.367 |
LIG_14-3-3_CanoR_1 | 20 | 27 | PF00244 | 0.693 |
LIG_14-3-3_CanoR_1 | 250 | 254 | PF00244 | 0.464 |
LIG_14-3-3_CanoR_1 | 354 | 358 | PF00244 | 0.417 |
LIG_14-3-3_CanoR_1 | 407 | 411 | PF00244 | 0.309 |
LIG_14-3-3_CanoR_1 | 418 | 426 | PF00244 | 0.335 |
LIG_14-3-3_CanoR_1 | 429 | 433 | PF00244 | 0.311 |
LIG_14-3-3_CanoR_1 | 490 | 498 | PF00244 | 0.361 |
LIG_14-3-3_CanoR_1 | 706 | 712 | PF00244 | 0.345 |
LIG_14-3-3_CanoR_1 | 76 | 84 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 96 | 104 | PF00244 | 0.452 |
LIG_Actin_WH2_2 | 465 | 482 | PF00022 | 0.274 |
LIG_APCC_ABBA_1 | 545 | 550 | PF00400 | 0.300 |
LIG_Clathr_ClatBox_1 | 112 | 116 | PF01394 | 0.427 |
LIG_EH_1 | 545 | 549 | PF12763 | 0.357 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.458 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.481 |
LIG_FHA_1 | 265 | 271 | PF00498 | 0.345 |
LIG_FHA_1 | 365 | 371 | PF00498 | 0.445 |
LIG_FHA_1 | 491 | 497 | PF00498 | 0.336 |
LIG_FHA_1 | 503 | 509 | PF00498 | 0.374 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.468 |
LIG_FHA_2 | 253 | 259 | PF00498 | 0.409 |
LIG_FHA_2 | 297 | 303 | PF00498 | 0.502 |
LIG_FHA_2 | 708 | 714 | PF00498 | 0.339 |
LIG_IBAR_NPY_1 | 561 | 563 | PF08397 | 0.306 |
LIG_Integrin_RGD_1 | 702 | 704 | PF01839 | 0.552 |
LIG_LIR_Apic_2 | 343 | 349 | PF02991 | 0.347 |
LIG_LIR_Apic_2 | 431 | 435 | PF02991 | 0.431 |
LIG_LIR_Apic_2 | 78 | 83 | PF02991 | 0.434 |
LIG_LIR_Gen_1 | 409 | 415 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 466 | 476 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 549 | 559 | PF02991 | 0.295 |
LIG_LIR_Gen_1 | 570 | 578 | PF02991 | 0.364 |
LIG_LIR_Gen_1 | 625 | 633 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 82 | 88 | PF02991 | 0.516 |
LIG_LIR_Nem_3 | 252 | 256 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 333 | 338 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 409 | 414 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 466 | 472 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 495 | 501 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 549 | 554 | PF02991 | 0.310 |
LIG_LIR_Nem_3 | 570 | 574 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 625 | 629 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 82 | 87 | PF02991 | 0.519 |
LIG_LRP6_Inhibitor_1 | 582 | 588 | PF00058 | 0.436 |
LIG_NRP_CendR_1 | 740 | 741 | PF00754 | 0.585 |
LIG_PCNA_yPIPBox_3 | 552 | 564 | PF02747 | 0.290 |
LIG_Pex14_2 | 80 | 84 | PF04695 | 0.443 |
LIG_SH2_CRK | 498 | 502 | PF00017 | 0.333 |
LIG_SH2_NCK_1 | 141 | 145 | PF00017 | 0.361 |
LIG_SH2_NCK_1 | 303 | 307 | PF00017 | 0.421 |
LIG_SH2_NCK_1 | 709 | 713 | PF00017 | 0.371 |
LIG_SH2_SRC | 450 | 453 | PF00017 | 0.376 |
LIG_SH2_STAP1 | 141 | 145 | PF00017 | 0.454 |
LIG_SH2_STAP1 | 450 | 454 | PF00017 | 0.464 |
LIG_SH2_STAP1 | 522 | 526 | PF00017 | 0.296 |
LIG_SH2_STAP1 | 578 | 582 | PF00017 | 0.299 |
LIG_SH2_STAT3 | 207 | 210 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.441 |
LIG_SH2_STAT5 | 324 | 327 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 391 | 394 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 460 | 463 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 469 | 472 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 475 | 478 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 534 | 537 | PF00017 | 0.268 |
LIG_SH2_STAT5 | 571 | 574 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 641 | 644 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 709 | 712 | PF00017 | 0.383 |
LIG_SH3_3 | 377 | 383 | PF00018 | 0.502 |
LIG_SH3_3 | 453 | 459 | PF00018 | 0.387 |
LIG_SH3_3 | 498 | 504 | PF00018 | 0.375 |
LIG_SH3_3 | 541 | 547 | PF00018 | 0.322 |
LIG_SH3_3 | 556 | 562 | PF00018 | 0.266 |
LIG_SH3_3 | 633 | 639 | PF00018 | 0.296 |
LIG_SUMO_SIM_anti_2 | 42 | 48 | PF11976 | 0.265 |
LIG_SUMO_SIM_anti_2 | 570 | 576 | PF11976 | 0.269 |
LIG_SUMO_SIM_anti_2 | 625 | 631 | PF11976 | 0.257 |
LIG_TRAF2_1 | 71 | 74 | PF00917 | 0.412 |
LIG_TYR_ITIM | 254 | 259 | PF00017 | 0.445 |
LIG_TYR_ITIM | 496 | 501 | PF00017 | 0.283 |
LIG_WW_1 | 10 | 13 | PF00397 | 0.609 |
MOD_CDK_SPxK_1 | 617 | 623 | PF00069 | 0.320 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.399 |
MOD_CK1_1 | 356 | 362 | PF00069 | 0.408 |
MOD_CK1_1 | 369 | 375 | PF00069 | 0.371 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.435 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.473 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.422 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.457 |
MOD_CK2_1 | 218 | 224 | PF00069 | 0.419 |
MOD_CK2_1 | 252 | 258 | PF00069 | 0.406 |
MOD_CK2_1 | 296 | 302 | PF00069 | 0.524 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.447 |
MOD_CK2_1 | 707 | 713 | PF00069 | 0.318 |
MOD_Cter_Amidation | 738 | 741 | PF01082 | 0.512 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.646 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.698 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.449 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.724 |
MOD_GlcNHglycan | 314 | 317 | PF01048 | 0.591 |
MOD_GlcNHglycan | 373 | 376 | PF01048 | 0.654 |
MOD_GlcNHglycan | 395 | 398 | PF01048 | 0.634 |
MOD_GlcNHglycan | 737 | 740 | PF01048 | 0.542 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.506 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.425 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.449 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.476 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.440 |
MOD_GSK3_1 | 365 | 372 | PF00069 | 0.404 |
MOD_GSK3_1 | 375 | 382 | PF00069 | 0.422 |
MOD_GSK3_1 | 413 | 420 | PF00069 | 0.288 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.494 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.469 |
MOD_GSK3_1 | 680 | 687 | PF00069 | 0.346 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.519 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.646 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.425 |
MOD_LATS_1 | 18 | 24 | PF00433 | 0.622 |
MOD_N-GLC_1 | 264 | 269 | PF02516 | 0.538 |
MOD_N-GLC_1 | 318 | 323 | PF02516 | 0.529 |
MOD_N-GLC_1 | 490 | 495 | PF02516 | 0.547 |
MOD_N-GLC_1 | 671 | 676 | PF02516 | 0.560 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.324 |
MOD_NEK2_1 | 428 | 433 | PF00069 | 0.378 |
MOD_NEK2_1 | 492 | 497 | PF00069 | 0.353 |
MOD_NEK2_1 | 521 | 526 | PF00069 | 0.286 |
MOD_NEK2_2 | 121 | 126 | PF00069 | 0.565 |
MOD_PIKK_1 | 214 | 220 | PF00454 | 0.458 |
MOD_PIKK_1 | 28 | 34 | PF00454 | 0.595 |
MOD_PIKK_1 | 438 | 444 | PF00454 | 0.451 |
MOD_PIKK_1 | 59 | 65 | PF00454 | 0.459 |
MOD_PIKK_1 | 671 | 677 | PF00454 | 0.345 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.413 |
MOD_PKA_1 | 418 | 424 | PF00069 | 0.482 |
MOD_PKA_2 | 13 | 19 | PF00069 | 0.638 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.511 |
MOD_PKA_2 | 162 | 168 | PF00069 | 0.368 |
MOD_PKA_2 | 219 | 225 | PF00069 | 0.451 |
MOD_PKA_2 | 249 | 255 | PF00069 | 0.467 |
MOD_PKA_2 | 280 | 286 | PF00069 | 0.407 |
MOD_PKA_2 | 353 | 359 | PF00069 | 0.431 |
MOD_PKA_2 | 406 | 412 | PF00069 | 0.369 |
MOD_PKA_2 | 417 | 423 | PF00069 | 0.440 |
MOD_PKA_2 | 428 | 434 | PF00069 | 0.371 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.437 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.445 |
MOD_Plk_1 | 365 | 371 | PF00069 | 0.377 |
MOD_Plk_1 | 90 | 96 | PF00069 | 0.393 |
MOD_Plk_2-3 | 150 | 156 | PF00069 | 0.422 |
MOD_Plk_2-3 | 280 | 286 | PF00069 | 0.407 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.496 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.426 |
MOD_Plk_4 | 249 | 255 | PF00069 | 0.408 |
MOD_Plk_4 | 320 | 326 | PF00069 | 0.350 |
MOD_Plk_4 | 353 | 359 | PF00069 | 0.391 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.309 |
MOD_Plk_4 | 406 | 412 | PF00069 | 0.321 |
MOD_Plk_4 | 570 | 576 | PF00069 | 0.306 |
MOD_Plk_4 | 622 | 628 | PF00069 | 0.401 |
MOD_Plk_4 | 685 | 691 | PF00069 | 0.325 |
MOD_ProDKin_1 | 318 | 324 | PF00069 | 0.323 |
MOD_ProDKin_1 | 345 | 351 | PF00069 | 0.495 |
MOD_ProDKin_1 | 379 | 385 | PF00069 | 0.454 |
MOD_ProDKin_1 | 617 | 623 | PF00069 | 0.337 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.471 |
MOD_SUMO_rev_2 | 413 | 421 | PF00179 | 0.347 |
MOD_SUMO_rev_2 | 573 | 583 | PF00179 | 0.259 |
MOD_SUMO_rev_2 | 649 | 659 | PF00179 | 0.297 |
TRG_DiLeu_BaEn_1 | 570 | 575 | PF01217 | 0.264 |
TRG_DiLeu_BaEn_1 | 655 | 660 | PF01217 | 0.309 |
TRG_DiLeu_BaLyEn_6 | 536 | 541 | PF01217 | 0.349 |
TRG_DiLeu_LyEn_5 | 655 | 660 | PF01217 | 0.307 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 452 | 455 | PF00928 | 0.476 |
TRG_ENDOCYTIC_2 | 469 | 472 | PF00928 | 0.246 |
TRG_ENDOCYTIC_2 | 498 | 501 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 571 | 574 | PF00928 | 0.397 |
TRG_ER_diArg_1 | 102 | 104 | PF00400 | 0.413 |
TRG_ER_diArg_1 | 211 | 213 | PF00400 | 0.394 |
TRG_ER_diArg_1 | 327 | 329 | PF00400 | 0.475 |
TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.624 |
TRG_ER_diArg_1 | 362 | 364 | PF00400 | 0.393 |
TRG_ER_diArg_1 | 538 | 540 | PF00400 | 0.344 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.653 |
TRG_NLS_MonoCore_2 | 486 | 491 | PF00514 | 0.291 |
TRG_NLS_MonoExtN_4 | 599 | 604 | PF00514 | 0.289 |
TRG_Pf-PMV_PEXEL_1 | 126 | 130 | PF00026 | 0.621 |
TRG_Pf-PMV_PEXEL_1 | 20 | 25 | PF00026 | 0.423 |
TRG_Pf-PMV_PEXEL_1 | 538 | 542 | PF00026 | 0.578 |
TRG_Pf-PMV_PEXEL_1 | 658 | 662 | PF00026 | 0.516 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IGN9 | Leishmania donovani | 84% | 91% |
A0A3S5H4Y6 | Leishmania donovani | 38% | 92% |
A0A3S5H4Y9 | Leishmania donovani | 33% | 75% |
A0A3S7WT86 | Leishmania donovani | 36% | 72% |
A0A3S7WWA6 | Leishmania donovani | 84% | 91% |
A0A451EJD9 | Leishmania donovani | 73% | 91% |
A0A451EJF4 | Leishmania donovani | 40% | 91% |
A0A451EJF6 | Leishmania donovani | 39% | 100% |
A0A451EJF8 | Leishmania donovani | 36% | 96% |
A0A451EJF9 | Leishmania donovani | 38% | 86% |
A4H3A9 | Leishmania braziliensis | 40% | 99% |
A4H3B4 | Leishmania braziliensis | 41% | 100% |
A4H3B5 | Leishmania braziliensis | 41% | 100% |
A4H3B6 | Leishmania braziliensis | 39% | 99% |
A4H3B8 | Leishmania braziliensis | 41% | 100% |
A4H3B9 | Leishmania braziliensis | 35% | 100% |
A4H4W8 | Leishmania braziliensis | 66% | 100% |
A4HJ20 | Leishmania braziliensis | 38% | 100% |
A4HNK3 | Leishmania braziliensis | 73% | 100% |
A4HNK6 | Leishmania braziliensis | 66% | 100% |
A4HRL9 | Leishmania infantum | 39% | 91% |
A4HRM0 | Leishmania infantum | 37% | 100% |
A4HRM1 | Leishmania infantum | 39% | 100% |
A4HRS1 | Leishmania infantum | 39% | 86% |
A4HRS3 | Leishmania infantum | 33% | 75% |
A4HRS5 | Leishmania infantum | 35% | 96% |
A4HZM0 | Leishmania infantum | 73% | 91% |
A4I7C7 | Leishmania infantum | 73% | 91% |
A4IAQ2 | Leishmania infantum | 70% | 91% |
E9AC91 | Leishmania major | 40% | 100% |
E9AC92 | Leishmania major | 41% | 100% |
E9AC95 | Leishmania major | 36% | 100% |
E9AC96 | Leishmania major | 39% | 100% |
E9AC98 | Leishmania major | 31% | 100% |
E9AEH8 | Leishmania major | 69% | 100% |
E9AHA6 | Leishmania infantum | 73% | 91% |
E9AIP8 | Leishmania braziliensis | 68% | 100% |
E9AJI3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
E9AJI4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
E9AJI5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
E9AJI6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9ASB8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 91% |
E9AXX8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 91% |
E9B2C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 91% |
Q4Q5T6 | Leishmania major | 70% | 100% |
Q4QCL8 | Leishmania major | 78% | 100% |
Q4QFJ3 | Leishmania major | 36% | 72% |
Q4QIG9 | Leishmania major | 79% | 100% |
Q7YXU9 | Leishmania major | 77% | 100% |
Q7YXV1 | Leishmania major | 79% | 100% |
Q7YXV2 | Leishmania major | 78% | 100% |